Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Barrett Esophagus-I: Introduction01:21

Barrett Esophagus-I: Introduction

1.1K
Barrett's esophagus is a medical condition where the esophageal mucosa is significantly damaged by stomach acid or other digestive fluids, often due to long-term exposure associated with gastroesophageal reflux disease (GERD). In GERD, a weakened or abnormally relaxed lower esophageal sphincter allows stomach acid to flow persistently into the esophagus.
This constant acid exposure transforms the esophagus's pink mucosal lining (stratified squamous epithelium) into a type of lining more...
1.1K
Barrett Esophagus-II: Clinical Manifestations and Management01:21

Barrett Esophagus-II: Clinical Manifestations and Management

1.4K
Individuals with Barrett's esophagus are often asymptomatic, but they may experience symptoms commonly associated with GERD, such as heartburn and acid regurgitation. Additional symptoms can include difficulty swallowing, chest pain, unintentional weight loss, blood in the stool (which may appear black, tarry, or bloody), and episodes of vomiting.
To diagnose Barrett's esophagus, healthcare providers often recommend an endoscopy for those showing symptoms of acid reflux. The procedure...
1.4K
Esophageal Strictures-I: Introduction01:30

Esophageal Strictures-I: Introduction

1.1K
Esophageal strictures involve abnormal narrowing or tightening of the esophagus. They vary in length and severity, ranging from mild constriction to complete obstruction, and are classified as benign (noncancerous) or malignant (cancerous).
Etiology
The primary cause of esophageal strictures is long-standing gastroesophageal reflux disease (GERD), accounting for about 70 to 80% of adult cases. Chronic acid reflux can lead to injury and scarring of the esophageal lining, culminating in...
1.1K
Esophageal Strictures-II: Clinical Features and Management01:26

Esophageal Strictures-II: Clinical Features and Management

841
Patients with esophageal strictures often experience a range of symptoms. Initially, they may have difficulty swallowing solid foods, which can progress to include liquids. Additional symptoms may involve chest pain or discomfort, regurgitating food and fluids, heartburn, unintentional weight loss, coughing or choking during meals, and hoarseness.
Healthcare providers should gather a comprehensive medical history and conduct a physical examination for diagnosis. If esophageal stricture is...
841
Esophagus01:24

Esophagus

4.3K
The esophagus, a muscular conduit linking the pharynx and stomach, measures roughly 10 inches (25.4 cm) and sits behind the trachea. It remains collapsed when not swallowing. The esophagus follows a predominantly straight path through the thoracic mediastinum and enters the abdominal cavity through a diaphragmatic opening known as the esophageal hiatus.
The movement of edibles from the pharynx into the esophagus is facilitated by the upper esophageal sphincter, which is formed primarily by the...
4.3K
Esophageal Varices-I: Introduction01:24

Esophageal Varices-I: Introduction

1.9K
Esophageal varices are dilated, tortuous veins which are found mainly in the submucosa of the lower esophagus but which may also appear higher up or extend into the stomach. They develop due to increased pressure in the portal venous system, often as a result of liver cirrhosis. This condition scars and damages the liver, impeding normal blood flow through the portal vein. To compensate, blood seeks alternative pathways, forming fragile new vessels (varices) in the esophagus and stomach. These...
1.9K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Gastro-oesophageal reflux disease-update 2021].

Der Internist·2020
Same author

[EndoStim® treatment-a new minimally invasive technology in antireflux surgery].

Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen·2018
Same author

Acute sedation-associated complications in GI endoscopy (ProSed 2 Study): results from the prospective multicentre electronic registry of sedation-associated complications.

Gut·2018
Same author

[Gastroenterological diseases as triggers of chest pain].

Der Internist·2016
Same author

[Diagnostic and therapeutic management of helicobacter pylori: a survey among German gastroenterologists in private practice].

Zeitschrift fur Gastroenterologie·2016
Same author

[Not Available].

MMW Fortschritte der Medizin·2016
Same journal

Der Internist·2024
Same journal

Der Internist·2024
Same journal

Der Internist·2024
Same journal

Der Internist·2024
Same journal

Der Internist·2024
Same journal

Der Internist·2024
See all related articles

Related Experiment Video

Updated: Mar 13, 2026

An Immunofluorescent Method for Characterization of Barrett’s Esophagus Cells
08:54

An Immunofluorescent Method for Characterization of Barrett’s Esophagus Cells

Published on: July 20, 2014

14.5K

[Barrett's esophagus].

J Labenz1

  • 1Innere Medizin, Diakonie Klinikum, Jung-Stilling-Krankenhaus Siegen, Wichernstr. 40, 57074, Siegen, Deutschland. j.labenz@t-online.de.

Der Internist
|October 28, 2016
PubMed
Summary
This summary is machine-generated.

Barrett's esophagus, a change in esophageal lining, is linked to acid reflux. While it slightly raises cancer risk, surveillance is recommended only for high-risk individuals.

Keywords:
Carcinoma, BarrettGastroesophageal refluxIntraepithelial neoplasms, low-gradeProton pump inhibitorsTherapy, endoscopic

More Related Videos

Diagnosis of Neoplasia in Barrett’s Esophagus using Vital-dye Enhanced Fluorescence Imaging
06:55

Diagnosis of Neoplasia in Barrett’s Esophagus using Vital-dye Enhanced Fluorescence Imaging

Published on: May 11, 2014

12.5K
Development of Compendium for Esophageal Squamous Cell Carcinoma
03:36

Development of Compendium for Esophageal Squamous Cell Carcinoma

Published on: April 12, 2024

896

Related Experiment Videos

Last Updated: Mar 13, 2026

An Immunofluorescent Method for Characterization of Barrett’s Esophagus Cells
08:54

An Immunofluorescent Method for Characterization of Barrett’s Esophagus Cells

Published on: July 20, 2014

14.5K
Diagnosis of Neoplasia in Barrett’s Esophagus using Vital-dye Enhanced Fluorescence Imaging
06:55

Diagnosis of Neoplasia in Barrett’s Esophagus using Vital-dye Enhanced Fluorescence Imaging

Published on: May 11, 2014

12.5K
Development of Compendium for Esophageal Squamous Cell Carcinoma
03:36

Development of Compendium for Esophageal Squamous Cell Carcinoma

Published on: April 12, 2024

896

Area of Science:

  • Gastroenterology
  • Oncology

Background:

  • Barrett's esophagus is characterized by metaplasia of the esophageal columnar epithelium.
  • It is frequently associated with gastroesophageal reflux disease (GERD).

Purpose of the Study:

  • To define Barrett's esophagus and its association with esophageal adenocarcinoma.
  • To outline current guidelines for screening, surveillance, and management.

Main Methods:

  • Endoscopic visualization and Prague classification for extent.
  • Histological confirmation of specialized intestinal metaplasia.
  • Review of current guideline recommendations for high-risk groups.

Main Results:

  • The absolute annual risk of esophageal adenocarcinoma in Barrett's esophagus is low (0.10-0.15%).
  • Screening and surveillance are recommended for high-risk populations only.
  • Endoscopic therapy is indicated for intraepithelial neoplasia, with pathology consultation for low-grade cases.

Conclusions:

  • Barrett's esophagus management focuses on risk stratification.
  • Current evidence does not support routine anti-reflux surgery for prevention.
  • The role of proton pump inhibitors in cancer progression remains debated.